BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30933310)

  • 21. α-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-β1 signaling in a Parkinson's disease model.
    Diniz LP; Matias I; Araujo APB; Garcia MN; Barros-Aragão FGQ; Alves-Leon SV; de Souza JM; Foguel D; Figueiredo CP; Braga C; Romão L; Gomes FCA
    J Neurochem; 2019 Jul; 150(2):138-157. PubMed ID: 31009074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
    Fifel K; Cooper HM
    Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent alterations in key components of the nigrostriatal dopaminergic system and distinct motor phenotypes.
    Fan JP; Geng HZ; Ji YW; Jia T; Treweek JB; Li AA; Zhou CY; Gradinaru V; Xiao C
    Acta Pharmacol Sin; 2022 Apr; 43(4):862-875. PubMed ID: 34244603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic adenosine A
    Morató X; Gonçalves FQ; Lopes JP; Jauregui O; Soler C; Fernández-Dueñas V; Cunha RA; Ciruela F
    J Neurochem; 2019 Mar; 148(6):796-809. PubMed ID: 30578680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.
    Ermine CM; Wright JL; Frausin S; Kauhausen JA; Parish CL; Stanic D; Thompson LH
    Hippocampus; 2018 May; 28(5):327-337. PubMed ID: 29431270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
    Ray A; Kambali M; Ravindranath V
    Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinctive Modulation of Dopamine Release in the Nucleus Accumbens Shell Mediated by Dopamine and Acetylcholine Receptors.
    Shin JH; Adrover MF; Alvarez VA
    J Neurosci; 2017 Nov; 37(46):11166-11180. PubMed ID: 29030431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.
    Zhang L; Le W; Xie W; Dani JA
    Neurobiol Aging; 2012 May; 33(5):1001.e7-16. PubMed ID: 21531044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson's disease model rats.
    Liu B; Xie J
    J Neurochem; 2004 Aug; 90(3):654-8. PubMed ID: 15255943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
    Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
    Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice.
    Zhang Y; Granholm AC; Huh K; Shan L; Diaz-Ruiz O; Malik N; Olson L; Hoffer BJ; Lupica CR; Hoffman AF; Bäckman CM
    Brain; 2012 Sep; 135(Pt 9):2736-49. PubMed ID: 22961549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty.
    Fujikawa A; Noda Y; Yamamoto H; Tanga N; Sakaguchi G; Hattori S; Song WJ; Sora I; Nabeshima T; Katsuura G; Noda M
    PLoS One; 2019; 14(8):e0221205. PubMed ID: 31430310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Nicotine Encoding Dopamine Release between the Striatum and Shell Portion of the Nucleus Accumbens.
    Chen YH; Lin BJ; Hsieh TH; Kuo TT; Miller J; Chou YC; Huang EY; Hoffer BJ
    Cell Transplant; 2019 Mar; 28(3):248-261. PubMed ID: 29807460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.
    Wang V; Kuo TT; Huang EY; Ma KH; Chou YC; Fu ZY; Lai LW; Jung J; Choi HI; Choi DS; Li Y; Olson L; Greig NH; Hoffer BJ; Chen YH
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):858-869. PubMed ID: 33860208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.
    Morgan RG; Gibbs JT; Melief EJ; Postupna NO; Sherfield EE; Wilson A; Keene CD; Montine TJ; Palmiter RD; Darvas M
    Exp Neurol; 2015 Sep; 271():205-14. PubMed ID: 26079646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats.
    Inaji M; Yoshizaki T; Okauchi T; Maeda J; Nagai Y; Nariai T; Ohno K; Ando K; Okano H; Obayashi S; Suhara T
    Cell Transplant; 2005; 14(9):655-63. PubMed ID: 16405076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.